) is a Denmark-headquartered developer, manufacturer, installer and servicer of wind turbines generating utility-scale electrical power. Founded in 1945 following the end of World War II, it is the world’s largest wind turbine company, employing a workforce of more than 25,000 and operates manufacturing plants in 16 countries spread across four continents.
VWDRY has installed more wind turbines than any other company in the renewable energy space, with over 122 GW of wind turbines in 82 countries. Last month, the company announced orders for a 504 MW installation in Colombia, a 51 MW order in Italy that included the installation of 11 wind turbines, and a 17 MW project in India.
3 Stocks to Own as Regional Banks Rebound
HIBS – Regional bank stocks Hingham Institution for Savings (HIFS), Webster Financial (WBS), and German American Bancorp (GABC) don’t get much attention, but they should. Here’s why.
Jan 7, 2021
In just the first few days of trading in 2021, regional bank stocks are soaring. The SPDR S&P Regional Banking ETF (KRE) is up more than 12%, while the S&P 500 is trading just 1.29% higher.
The banking industry saw more than its fair share of challenges in 2020, ranging from the closure of branches due to the coronavirus pandemic, to the increased competition from non-bank fintechs. The Deloitte Center for Financial Services is estimating that the U.S. banking industry may have to provision for a total of $318 billion in net loan losses from 2020 to 2022, which would represent 3.2% of loans.
Most Popular Stories on StockNews.com
Why Are Stocks Struggling with 4,000? The S&P 500 (SPY) has flirted with a series of moves up towards 4,000. Each time we fall short. And each time we either see a volatile pullback or nasty sector rotation. The latter seems to be more of what is happening at this time. So let’s dissect the action to plot our trading plan forward including insight on the top 10 stocks and 3 ETFs for today’s market environment. Read on…
Mar 24, 2021 | 2:30pm
3 Stocks that Wall Street Thinks Will Double Wall Street is betting on the biotech industry. Many biopharma stocks are close to developing drugs for chronic and life-threatening ailments. With impressive clinical trial results and growth potential, we believe stocks such as Immunovant (IMVT), Zogenix (ZGNX), and Spectrum Pharmaceuticals (SPPI) might double in value in the near term. Let’s discuss.
MJ) and AdvisorShares Pure US Cannabis ETF (
MSOS), have taken different strategies in pursuit of their targeted sector.
The Summit, New Jersey-based ETFMG Alternative Harvest ETF (MJ) was founded in 2014 and targets the global cannabis industry by tracking the Prime Alternative Harvest Index. The top holding in its portfolio is its $10.03 share of Canada’s Aphria Inc. (
APHA), followed by an 8.43% share of Britain’s GW Pharmaceuticals plc (
The Bethesda, Maryland-based AdvisorShares Pure US Cannabis ETF (MSOS) only began trading on Sept. 2 of this year and concentrates
solely on cannabis-related businesses within the U.S. market, investing at least 80% of its net assets in the securities of U.S. companies that derive at least half of their net revenue from marijuana and hemp businesses. Slightly more than half of its portfolio belongs to BlackRock Liquidity Funds Treasury Trust Institutional (